journal cover

Genetic Variants Within Molecular Targets of Antipsychotic Treatment: Effects on Treatment Response, Schizophrenia Risk, and Psychopathological Features

Journal of Molecular Neuroscience : MN

Nov 23, 2017

Marco CalabròAlessandro Serretti

Download from

Publisher
PubMed

Abstract

Schizophrenia (SCZ) is a common and severe mental disorder. Genetic factors likely play a role in its pathophysiology as well as in treatment response. In the present study, we investigated the effects of several single nucleotide polymorphisms (SNPs) within 9 genes involved with antips...read more

Mentioned in this Paper

Study
Antipsychotic Effect
MAPK1 gene
COMT gene
PLA2G4A gene
Receptors, sigma
Genes
Schizophrenia
Research Subject
Chrna7 protein, human
1
28
Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Feeds With Similar Papers

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Environment & Astrocyte Proinflammation

Environmental factors play a role in neurological diseases and in particular their contribution in astrocyte proinflammation is of interest. The activation of astrocytes may be involved in neuroinflammation and implicated in neurodegenerative diseases. Here is the latest research on environment and astrocyte proinflammation.

Risk for Schizophrenia

Schizophrenia is a complex disease and emerging studies have identified hundreds of genetic loci harbouring schizophrenia-associated variants. These variants can potentially increase the risk for developing Schizophrenia. Discover the latest research on Risk For Schizophrenia here.

© 2020 Meta ULC. All rights reserved

Genetic Variants Within Molecular Targets of Antipsychotic Treatment: Effects on Treatment Response, Schizophrenia Risk, and Psychopathological Features

Journal of Molecular Neuroscience : MN

Nov 23, 2017

Marco CalabròAlessandro Serretti

PMID: 29164477

DOI: 10.1007/s12031-017-1002-1

Abstract

Schizophrenia (SCZ) is a common and severe mental disorder. Genetic factors likely play a role in its pathophysiology as well as in treatment response. In the present study, we investigated the effects of several single nucleotide polymorphisms (SNPs) within 9 genes involved with antips...read more

Mentioned in this Paper

Study
Antipsychotic Effect
MAPK1 gene
COMT gene
PLA2G4A gene
Receptors, sigma
Genes
Schizophrenia
Research Subject
Chrna7 protein, human
1
28

Feeds With Similar Papers

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Environment & Astrocyte Proinflammation

Environmental factors play a role in neurological diseases and in particular their contribution in astrocyte proinflammation is of interest. The activation of astrocytes may be involved in neuroinflammation and implicated in neurodegenerative diseases. Here is the latest research on environment and astrocyte proinflammation.

Related Papers

Psychiatric Genetics

CACNA1C gene and schizophrenia: a case-control and pharmacogenetic study

Psychiatric GeneticsJune 8, 2015
Stefano PorcelliChi-Un Pae
Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Download from

Publisher
PubMed
/papers/genetic-variants-within-molecular-targets-of/29164477